SCHEMBL1901625

SCHEMBL1901625

CCN(CC)CCCNC(=O)c1cc2c(Oc3ccc(NC(=O)Nc4ccc(F)cc4)cc3)ncnc2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 5/20 0.51
HRH3 Q9Y5N1 2/20 0.47
CSF1R P07333 4/20 0.47
MCHR1 Q99705 5/20 0.46
KDR P35968 5/20 0.46
FLT1 P17948 2/20 0.46
POLB P06746 1/20 0.42
AURKA O14965 1/20 0.42
PAK4 O96013 1/20 0.42
ABL1 P00519 1/20 0.42
NTRK1 P04629 1/20 0.42
LCK P06239 1/20 0.42
FYN P06241 1/20 0.42
RET P07949 1/20 0.42
MET P08581 1/20 0.42
PDGFRB P09619 1/20 0.42
FGFR1 P11362 1/20 0.42
PDGFRA P16234 1/20 0.42
LTK P29376 1/20 0.42
MAP2K2 P36507 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12411691 0.81 EPHX2 (0.51) FLT3MCHR1KDRFLT1AURKA
SCHEMBL1890715 0.80 FLT3 (0.58) FLT3CSF1RKDRPDGFRA
SCHEMBL1892088 0.79 FLT3 (0.65) FLT3CSF1RKDRPDGFRBPDGFRA
SCHEMBL1889586 0.75 FLT3 (0.64) FLT3CSF1RKDRPDGFRBPDGFRA
SCHEMBL12411688 0.74 FLT3 (0.57) FLT3CSF1RKDRMAPK14
SCHEMBL1895440 0.73 FLT3 (0.56) FLT3HRH3CSF1RKDRAURKA
SCHEMBL1895572 0.73 FLT3 (0.64) FLT3CSF1RKDRPDGFRBPDGFRA
SCHEMBL1895590 0.71 CSF1R (0.64) FLT3CSF1RKDRMAPK14
SCHEMBL13548332 0.70 AXL (0.65) FLT3KDRFLT1AURKAABL1
SCHEMBL12499716 0.69 FLT3 (0.56) FLT3CSF1RKDRFLT1MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8372981-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-02-12 US disclosed
US-20110118470-A1 NITROGEN-CONTAINING AROMATIC DERIVATIVES FUNAHASHI YASUHIRO 2011-05-19 US disclosed
EP-1506962-B1 Nitrogen-containing aromatic heterocycles EISAI R&D MAN CO LTD (JP) 2008-07-02 EP disclosed
EP-1777218-A1 Process for the preparation of 4-phenoxy quinoline derivatives Eisai R&D Management Co., Ltd. (JP) 2007-04-25 EP disclosed
EP-1506962-A2 Nitrogen-containing aromatic heterocycles Eisai Co. Ltd. (JP) 2005-02-16 EP disclosed
EP-1415987-A1 NITROGENOUS AROMATIC RING COMPOUNDS Eisai Co., Ltd. (JP) 2004-05-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118470-A1 NITROGEN-CONTAINING AROMATIC DERIVATIVES GNG2, GCG, FRG1 FLT3 1310/4885HRH3 157/4885CSF1R 2032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.